FDA UNTITLED_LETTER - The Compounding Pharmacy of Beverly Hills - September 17, 2020

Record Details

This UNTITLED LETTER record concerns The Compounding Pharmacy of Beverly Hills, with an inspection on September 17, 2020, covering drugs.

Company: The Compounding Pharmacy of Beverly Hills
Inspection Date: September 17, 2020
Product Type: Drugs
Person: Steven E. Porter (Program Division Director)

Open in Dashboard

ID · a9777c34-3062-4d64-9ae7-3a9c83ff0587

Violation Codes9

21 U.S.C. 351(a)(2)(B)21 U.S.C. 355(a)21 U.S.C. 352(f)(1)FD&C Act 501(a)(2)(B)21 U.S.C. 331(k)FD&C Act 502(f)(1)FD&C Act 50521 U.S.C. 353a21 CFR 201.115

Full citation text and observation details available on the Dashboard.